The overexpression of multidrug resistance-associated proteins and gankyrin contribute to arsenic trioxide resistance in liver and gastric cancer cells.
about
Factors determining sensitivity and resistance of tumor cells to arsenic trioxideNutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.Near infrared imaging of EGFR of oral squamous cell carcinoma in mice administered arsenic trioxideDownregulation of P-gp, Ras and p-ERK1/2 contributes to the arsenic trioxide-induced reduction in drug resistance towards doxorubicin in gastric cancer cell lines.Up-regulated oncoprotein P28GANK correlates with proliferation and poor prognosis of human glioma.Targeted imaging and induction of apoptosis of drug-resistant hepatoma cells by miR-122-loaded graphene-InP nanocompoundsABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients.Modulating autophagy: a strategy for cancer therapyMicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24.Disruption of p73-MDM2 binding synergizes with gemcitabine to induce apoptosis in HuCCT1 cholangiocarcinoma cell line with p53 mutation.Nutlin-3 cooperates with doxorubicin to induce apoptosis of human hepatocellular carcinoma cells through p53 or p73 signaling pathways.Proteomic Study to Survey the CIGB-552 Antitumor EffectUnexpected Lower Expression of Oncoprotein Gankyrin in Drug Resistant ABCG2 Overexpressing Breast Cancer Cell LinesPhenylarsine oxide (PAO) induces apoptosis in HepG2 cells via ROS-mediated mitochondria and ER-stress dependent signaling pathways.Kanglaite reverses multidrug resistance of HCC by inducing apoptosis and cell cycle arrest via PI3K/AKT pathway.Multifactorial Modes of Action of Arsenic Trioxide in Cancer Cells as Analyzed by Classical and Network Pharmacology.
P2860
Q28483625-28F104B1-E399-4A93-A51F-48D67BAABBD9Q33713544-FB55C48E-72B1-4AA1-8A09-691CB7B3A6F9Q34430979-18B438F2-E753-4F54-93A0-38797D6E9C48Q36224699-D54D35CB-B6B8-4851-B136-20901211EA8FQ36235734-65B20AD4-B5A8-4A22-A64C-7D9668D8F6A1Q37602690-D3E522DF-1C26-418B-807C-E555D223461FQ37688251-A3A4F98E-AD17-40D5-9EA8-2CE39C52C52AQ37940741-ADBCDF4D-8974-48BB-9183-731A2370051CQ39653380-89E69459-33F7-44C5-B04B-271F767A141DQ39710403-5E28D60D-E30E-48B5-BC4F-A8C3134503A2Q39736810-6CA7BF5C-D230-4D68-9FB1-EA1B1048C2EFQ42608215-E46C04F0-4A2F-4026-8621-578CF923160EQ47245509-EA237BE4-54B1-4D29-977E-14475FD50C51Q47918806-81EA4E82-45C8-4808-B302-5F6A1C54C38BQ52727759-18ECF616-5E9F-4000-8F76-1271AC15BFE3Q53702218-9868549F-184C-45A9-B5B5-2BD4964F5E49
P2860
The overexpression of multidrug resistance-associated proteins and gankyrin contribute to arsenic trioxide resistance in liver and gastric cancer cells.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
The overexpression of multidru ...... iver and gastric cancer cells.
@en
The overexpression of multidru ...... iver and gastric cancer cells.
@nl
type
label
The overexpression of multidru ...... iver and gastric cancer cells.
@en
The overexpression of multidru ...... iver and gastric cancer cells.
@nl
prefLabel
The overexpression of multidru ...... iver and gastric cancer cells.
@en
The overexpression of multidru ...... iver and gastric cancer cells.
@nl
P2093
P356
P1433
P1476
The overexpression of multidru ...... iver and gastric cancer cells.
@en
P2093
P356
10.3892/OR_00000410
P577
2009-07-01T00:00:00Z